The Journal of Infectious Diseases recently published a study focused on whether there are interactions that occur between the SARS-CoV-2 coronavirus and Streptococcus pneumoniae.
This research published on March 9, 2021, found after adjusting for risk factors and other exposures, seniors (65+ years) who had received a 13-valent pneumococcal conjugate vaccine (PCV13) experienced a lower incidence of COVID-19 diagnosis, hospitalization, and death.
Read More
